Boston Children’s Hospital and Life Technologies Launch Claritas Genomics, a Clinical Genomics Company

January 8, 2013 Spinoff venture will develop genomic sequencing solutions utilizing Ion Torrent technology for clinical applications SAN FRANCISCO, Jan. 8, 2013 /PRNewswire-USNewswire/ — Boston Children’s Hospital has partnered with Life Technologies Corporation(NASDAQ: LIFE) to launch Claritas Genomics, a new company formed to develop next-generation, genetic and genomics-based diagnostic testing solutions. The venture combines advanced instrumentation, software and bioinformatics capabilities with sophisticated clinical…

Read More

Exome Sequencing for Researchers

Claritas Genomics is pleased to announce that it is now a Certified Service Provider in the Life Technologies Ion AmpliSeq™ Exome network. Through this program, Claritas Genomics offers Ion AmpliSeq™ Exome Sequencing Research Services using the Ion Proton System. Researchers will receive high-quality sequencing data and will have access to the Ion Reporter™ software for annotation and further analysis. Base…

Read More

Claritas Genomics & NextCODE Health announce partnership

CAMBRIDGE, Mass., Dec. 11, 2014 To rapidly expand the use and power of genomic sequencing for diagnosing and treating rare diseases, Claritas Genomics and NextCODE Health today announced a strategic partnership bringing together global leadership in pediatric medicine and sequence analysis. Claritas Genomics, affiliated with Boston Children’s Hospital, is a CLIA-certified clinical laboratory serving the DNA-based…

Read More

Elizabeth Boudreau, Senior Manager of Information Technology, spoke at the AWS Public Sector Symposium on June 26, 2014

Elizabeth Boudreau, Claritas’s Senior Manager of Information Technology, was invited by Amazon Web Services to speak at the June conference in Washington, DC. The conference, “AWS Government, Education, and Nonprofits Symposium,” invited leaders in public sectors to learn more about how the AWS cloud can support their work. Ms. Boudreau’s presentation, entitled “Enhancing Genetic Computation…

Read More

Cincinnati Children’s Joins Boston Children’s to Establish the Claritas Pediatric Genomic Network

FOR IMMEDIATE RELEASE Nov 12, 2013 Pediatric hospitals to share data and genomic testing infrastructure for the benefit of patients Cambridge, Nov 12— Cincinnati Children’s Medical Center has partnered with Claritas Genomics, a company formed by Boston Children’s Hospital and Life Technologies Corporation (NASDAQ: LIFE), to provide genomics-based diagnostics for pediatric patients. Cincinnati Children’s will work…

Read More

News | Page 2

News Cerner and Claritas Genomics Will Collaborate to Advance Personalized Medicine FOR IMMEDIATE RELEASE Dec 5, 2013 KANSAS CITY, Mo. and CAMBRIDGE, Mass., Dec 05, 2013 (GLOBE NEWSWIRE via COMTEX) — Cerner Corp. CERN -0.14% and Claritas Genomics announce that the companies will work together to advance personalized medicine by building tools and connectivity that…

Read More

Send-out Management Program

Use Claritas’s Concierge Send-Out Management Program to Save Money on Genetic Testing If your institution sends out genetic tests to a diverse array of laboratories, Claritas can help you manage the process. Our program not only reduces the time, cost, and effort that you spend managing send-outs, but our MERIT committee (Molecular Expertise Realizing Improvements…

Read More

News

News Claritas Genomics to Present 4 Posters and a Talk ‘Phenotype First: The Power of a Tailored Exome’ at ACMG Annual Clinical Genetics Meeting CAMBRIDGE, Mass., March 24, 2015 /PRNewswire-USNewswire/ — Claritas Genomics will present data on the quality of parallel multi-technology sequencing, a comparison of the company’s phenotypically driven Pediatric Neurology Exome Assay to whole exome…

Read More

Claritas Announces Launch of ClariFocus Exome Family of Tests

CAMBRIDGE, MA – July 31 Claritas Genomics, a clinical laboratory serving the DNA-based diagnostic testing needs of children’s hospitals, announced today that it is launching a novel series of clinical assays that combine the flexibility and comprehensiveness of whole exome sequencing with the rigor of deep and focused analysis of variants associated with specific clinical…

Read More